Jonathan Anderman, General Counsel & Corporate Secretary at Compass Therapeutics, Inc. (CMPX), bought 20,000 shares at $1.54 ($31K) on 2025-04-07, disclosed to the SEC on 2025-04-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.